ClinicalTrials.gg
Sign In

Neurologic Manifestations clinical trials

The registry lists 425 studies for Neurologic Manifestations across more than 10 countries. 82 are recruiting or about to start. 77 of them are mainly about Neurologic Manifestations (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 200 narrower conditions too, such as Pain: 48,535 studies, 10,132 open.

Get an email when these change. Save the Neurologic Manifestations studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
232
Recruiting
59
Status unknown
44
Terminated
26
Active, not recruiting
23
Not yet recruiting
23

Phase

Phase 2
59
Phase 3
40
Phase 1
32
Phase 4
9
Early Phase 1
4

Where

United States
185
Canada
31
France
24
China
24
Italy
16
United Kingdom
14

Who runs them

National Center for Research Resources (NCRR) (28) · National Institute of Neurological Disorders and Stroke (NINDS) (17) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (8) · H. Lee Moffitt Cancer Center and Research Institute (7) · Vanderbilt University Medical Center (6) · Stanford University (6) · National Heart, Lung, and Blood Institute (NHLBI) (6) · Medical University of South Carolina (5)

What is being tested here

Drugs under test in Neurologic Manifestations studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Islet Amyloid Polypeptide202
Sepofarsen134
Dexmedetomidine102
Disulfiram101
CHT101101
MT027101
Nicotinamide-beta-riboside101
Autologous Anti-B7-H3 CAR T Cells101
Sugammadex101
Neostigmine101

Drug classes tested here Alkylating agents 6 · Tyrosine kinase inhibitors (TKIs) 3 · Dopamine agonists 3 · Antipsychotics 3

Coming up

9phase 3 studies under way
25studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 59 Neurologic Manifestations studies recruiting now, 31 (53%) set no upper age limit and 14 (24%) stop at 75 or younger. 15 (25%) take children under 18. 1 (2%) are for women only and 0 (0%) for men only; 13 (22%) take healthy volunteers.

Recruiting studies that take each age, of 59
AgeWomenMen
1013 (22%)12 (20%)
1848 (81%)47 (80%)
3053 (90%)52 (88%)
4052 (88%)51 (86%)
5050 (85%)50 (85%)
6550 (85%)50 (85%)
7548 (81%)48 (81%)
8536 (61%)36 (61%)

Across all 425 studies, recruiting or not: 39% stop at 75 or younger and 30% at 65; 32% take children; 3% are for women only and 3% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Neurologic Manifestations studies take

Of 71 interventional studies with no phase under Neurologic Manifestations, half reached primary completion within 39 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase39 mo12–67 · 71 studies—41 mo17–80 · 63 studies
Observational39 mo22–339 · 59 studies—40 mo26–339 · 52 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Stopped1

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 425. Browse all 425 → or search them.